** Medical device maker Microbot Medical's MBOT.O shares up 50% at $2.08
** MBOT says its experimental endovascular robotic system, Liberty, met main goal in the study
** Endovascular robotic system assists doctors on minimally invasive surgeries inside blood vessels for treating aneurysms, blockages and other vascular issues
** "Mean difference in radiation exposure between operator and control was (-)29.8 µS, resulting in a mean 92% relative reduction in radiation exposure" - MBOT
** Some robotic systems use radiation-based imaging techniques, like X-rays or gamma rays
** Company says no adverse device events were reported during the study
** Up to last close, stock has risen 24.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.